Clincosm LogoSign in Get a demo

Recurrent Non Small Cell Lung Cancer

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jan 12, 2023

Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Tumor-infiltrating Lymphocytes (TIL)
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Garmin Vivofit Activity Tracker
  • (no location specified)
Aug 31, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in United States (Amivantamab, Lazertinib)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 1, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in Philadelphia (Etirinotecan pegol

Completed
Has Results
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Etirinotecan pegol (NKTR-102)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 1, 2020

Recurrent Non Small Cell Lung Cancer Trial in Baltimore, Tiong Bahru Estate (Itraconazole, Pemetrexed)

Terminated
Has Results
  • Recurrent Non Small Cell Lung Cancer
  • Baltimore, Maryland
  • +1 more
Jan 30, 2019

Recurrent Non Small Cell Lung Cancer Trial in United States (apricoxib/erlotinib, erlotinib/)

Completed
Has Results
  • Recurrent Non Small Cell Lung Cancer
  • Tucson, Arizona
  • +46 more
Mar 13, 2012